| CSB00025 | 重组人红细胞生成素注射液 | Human Erythropoietin | Injection | Biological Products(2) | Supplementary Application | 2000-10-18 | 沈阳三生制药股份有限公司 | Shenyang Sunshine Pharmaceutical Co Ltd | In Approval | | view |
| CYSB2200263 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2022-11-22 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CXSL2400408 | 注射用SSGJ-709 | SSGJ-709 | Lyophilized | Biological Products(1) | New Drug Application | 2024-06-22 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CYSB2200215 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2022-08-26 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CXSL2200509 | 人源化神经生长因子抗体注射液 | | Injection | Biological Products(1) | New Drug Application | 2022-10-11 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CYSB2400175 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2024-07-09 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CYSB2200266 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2022-11-22 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CXHL2400204 | SSS39注射剂 | SSS-39 | Injection | Chemical Drugs(1) | New Drug Application | 2024-02-21 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CYSB2200265 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2022-11-22 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CXSS2200088 | 重组人血小板生成素注射液 | recombinant human thrombopoietin | Injection | Biological Products(2.2) | New Drug Application | 2022-11-02 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CYSB2400174 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2024-07-09 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CYSB2200216 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2022-08-26 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CXSB2101002 | 人源化抗人TNFα单克隆抗体注射液（CHO细胞） | adalimumab | Injection | Biological Products(1) | Supplementary Application | 2021-03-18 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CXSB2300100 | 重组红细胞生成刺激蛋白注射液（CHO细胞） | | Injection | Biological Products(原9) | Supplementary Application | 2023-09-19 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CXSS2200089 | 重组人血小板生成素注射液 | recombinant human thrombopoietin | Injection | Biological Products(2.2) | New Drug Application | 2022-11-02 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CYSB2400178 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2024-07-09 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CYSB2200217 | 人促红素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2022-08-26 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CXSB0890001 | 重组人红细胞生成素注射液 | Human Erythropoietin | Injection | Biological Products | Supplementary Application | 2008-10-07 | 沈阳三生制药股份有限公司 | Shenyang Sunshine Pharmaceutical Co Ltd | Approval Completed-Pending Certificated | | view |
| CYSB2300022 | 重组人血小板生成素注射液 | recombinant human thrombopoietin | Injection | Biological Products | Supplementary Application | 2023-01-30 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
| CXSB2200096 | 人源化抗人TNFα单克隆抗体注射液（CHO细胞） | adalimumab | Injection | Biological Products(1) | Supplementary Application | 2022-11-08 | | Shenyang Sunshine Pharmaceutical Co Ltd | | | view |
